Skip to main content

. 1998 Sep;51(9):641–642. doi: 10.1136/jcp.51.9.641

Antiganglioside antibodies in peripheral neuropathies.

PMCID: PMC500896 PMID: 9930063

641

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Ho T. W., Mishu B., Li C. Y., Gao C. Y., Cornblath D. R., Griffin J. W., Asbury A. K., Blaser M. J., McKhann G. M. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 1995 Jun;118(Pt 3):597–605. doi: 10.1093/brain/118.3.597. [DOI] [PubMed] [Google Scholar]
Lang B., Vincent A. Autoimmunity to ion-channels and other proteins in paraneoplastic disorders. Curr Opin Immunol. 1996 Dec;8(6):865–871. doi: 10.1016/s0952-7915(96)80017-3. [DOI] [PubMed] [Google Scholar]
Rees J. H., Gregson N. A., Hughes R. A. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol. 1995 Nov;38(5):809–816. doi: 10.1002/ana.410380516. [DOI] [PubMed] [Google Scholar]
Willison H. J., O'Hanlon G. M., Paterson G., Veitch J., Wilson G., Roberts M., Tang T., Vincent A. A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. J Clin Invest. 1996 Mar 1;97(5):1155–1164. doi: 10.1172/JCI118529. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES